Using HTA methods and early value assessment to optimize evidence generation plans
Expert Workshop
February 14th, 2024 – 9am-10am ET / 2:00-3:00pm GMT
Moderated by Noemi Muszbek
HE Director, Partner, Visible Analytics

Ascenian and Visible Analytics are co-hosting a live webinar this February.
Join our experts as they answer your questions and explore how early HTA activities and early value assessment can inform asset valuation, investment decisions, study design and market access strategy.

Prof. Neil Hawkins
HTA Director, Partner, Visible Analytics, UK

Maryanne Maliwat
Sr. Director, Pricing, Reimbursement, & Market Access, Regenxbio, USA

Prof. Dr. Marc Bardou
Economic and Public Health Committee, HAS, France

Dr. Susanne Michel
Former Department of Health in Berlin, Ascenian, Germany